Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
SoftOx Solutions AS ( (DE:6FV) ) just unveiled an update.
SoftOx Solutions AS has finalized a financing agreement with Long State Investments Limited, issuing 15 million shares as part of a 30 million share implementation fee. The private placement, which deviates from shareholders’ preferential rights, was deemed necessary by the board to secure timely funding, and a subsequent offering was not pursued due to cost considerations.
More about SoftOx Solutions AS
SoftOx Solutions AS is a clinical-stage pharmaceutical company listed on Euronext Growth Oslo. It focuses on developing pan-antimicrobial pharmaceuticals targeting bacteria, viruses, and fungi, leveraging research and development partnerships with leading Nordic research institutes.
YTD Price Performance: 442.86%
Average Trading Volume: 17,660,938
Current Market Cap: NOK172.8M
For a thorough assessment of 6FV stock, go to TipRanks’ Stock Analysis page.